On Monday, Artiva Biotherapeutics Inc (NASDAQ: ARTV) was 90.91% up from the session before settling in for the closing price of $3.3. A 52-week range for ARTV has been $1.47 – $11.55.
A company in the Healthcare sector has dropped its sales by -64.01% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 41.14%. With a float of $12.84 million, this company’s outstanding shares have now reached $24.54 million.
Artiva Biotherapeutics Inc (ARTV) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Artiva Biotherapeutics Inc stocks. The insider ownership of Artiva Biotherapeutics Inc is 47.68%, while institutional ownership is 53.14%. The most recent insider transaction that took place on Dec 15 ’25, was worth 19,122. In this transaction President and CEO of this company sold 3,187 shares at a rate of $6.00, taking the stock ownership to the 1,209,948 shares. Before that another transaction happened on Dec 15 ’25, when Company’s Director proposed sale 12,749 for $3.30, making the entire transaction worth $42,072.
Artiva Biotherapeutics Inc (ARTV) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 41.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.02% during the next five years compared to -64.01% drop over the previous five years of trading.
Artiva Biotherapeutics Inc (NASDAQ: ARTV) Trading Performance Indicators
You can see what Artiva Biotherapeutics Inc (ARTV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.25, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.36 in one year’s time.
Technical Analysis of Artiva Biotherapeutics Inc (ARTV)
Let’s dig in a bit further. During the last 5-days, its volume was 9.65 million. That was better than the volume of 0.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 46.59%.
During the past 100 days, Artiva Biotherapeutics Inc’s (ARTV) raw stochastic average was set at 79.38%, which indicates a significant increase from 77.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.50 in the past 14 days, which was higher than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.69, while its 200-day Moving Average is $2.96. However, in the short run, Artiva Biotherapeutics Inc’s stock first resistance to watch stands at $7.67. Second resistance stands at $9.05. The third major resistance level sits at $10.84. If the price goes on to break the first support level at $4.50, it is likely to go to the next support level at $2.71. Assuming the price breaks the second support level, the third support level stands at $1.33.
Artiva Biotherapeutics Inc (NASDAQ: ARTV) Key Stats
There are 24,545K outstanding shares of the company, which has a market capitalization of 154.64 million. As of now, sales total 250 K while income totals -65,370 K. Its latest quarter income was 0 K while its last quarter net income were -21,530 K.
